Skip to content

Prospective Study of the sensiTVT

Prospective Study of the sensiTVT (Midurethral Sling) for the Surgical Treatment of Stress Urinary Incontinence

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03603535
Acronym
sensiTVT
Enrollment
35
Registered
2018-07-27
Start date
2018-10-08
Completion date
2023-09-30
Last updated
2025-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Urinary Incontinence

Keywords

Stress urinary incontinence, objective outcome

Brief summary

sensiTVT is a relatively new tape. The aim of this study is to analyze the objective and subjective outcome at one year follow-up.

Detailed description

Stress urinary incontinence (SUI) is defined as the involuntary leakage during physical activity and situations that result in an increase of abdominal pressure like sneezing, coughing or laughing and affects up to 25% of women. Currently there are a number of tapes on the market with GYNECARE TVT EXACT® (Tension free Vaginal Tape) and TVT- Obturator being one of the tapes with the highest subjective and objective cure rates and relatively low adverse events in women with normal sphincter pressure. Due to the recent FDA announcements several tapes have been withdrawn from the market and several new ones have been designed. Data from other tapes are available, however data especially from newer tapes is lacking.

Interventions

DEVICEsensiTVT

The study is designed as a prospective single arm study. All women with an indication for suburethral tape placement for therapy of SUI and meeting the inclusion criteria will be offered study participation to record the objective outcome after one year.

Sponsors

Medical University Innsbruck
CollaboratorOTHER
Medical University of Graz
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Planned surgery for verified predominant stress urinary incontinence * women between 18 and 80 years of age * good German language skills * informed consent

Exclusion criteria

* Pregnant or lactating women * Active surgical treatment for invasive malignant diseases within 3 months * Contraindications for surgery or anesthesia * Severe neurologic disease * Concomitant prolapse surgery

Design outcomes

Primary

MeasureTime frameDescription
objective success of stress urinary incontinenceone yeardetermined by a standardized cough stress test at 300 ml bladder, a negative cough stress test is a success.

Secondary

MeasureTime frameDescription
Peri- and postoperative complications3 months+ one yearany surgical complications recorded
Subjective incontinence cure rate using the Incontinence Outcome Questionnaire3 months+ one yearThe Incontinence Outcome Questionnaire was validated for postoperative assessment of quality of life after surgical treatment for stress urinary incontinence and has 27 items with lower scores indicating worse treatment outcome. The total score is calculated.
quality of life using the Kings Health Questionnaire3 months+ one yearThe Kings Health Questionnaire was validated in women with stress urinary incontinence and assesses the impact of incontinence on quality of life. The eight subscales (domains) scored between 0 (best) and 100 (worst). The Symptom Severity scale is scored from 0 (best) to 30 (worst); lower scores indicate better QoL. Success in terms of the study is defined as 10 points improvement on the total Kings Health Questionnaire score.
Subjective bother using the Patient Global Impression of Severity3 months+ one yearPatient Global Impression of Severity The Patient Global Impression of Severity is a 7-item urinary symptom severity scale that is used to rate the severity of a specific condition -a single-state scale. The higher the number the worse the outcome of subjective bother of stress urinary incontinence.
Patient satisfaction measured using a visual analogue scale3 months+ one yearPatient satisfaction is defined as a score 8 to 10 on a 10-point visual analogue scale
Subjective success as determined using the Patient Global Impression of Improvement questionnaire.3 months+ one yeardefined as very much improved/much improved (1,2) on the Patient Global Impression of Improvement scale, while any other response (improved, same, worse, or much worse- 3-7) will be considered as failures. The Patient Global Impression of Improvement is a seven item scale validated for incontinence.
Erosion rate3 months+ one yearErosion rate from the tape in the vagina or bladder
Reoperation rate3 months+ one yearReoperation rate
De novo urgency3 months+ one yearDe novo OAB- overactive bladder as determined by clinical history taking
De novo pain in the operated region3 months+ one yearDe novo pain in the operated region as determined by clinical history taking
Sexual health using the Pelvic Organ Prolapse Incontinence Sexual Questionnaire3 months+ one yearThe Pelvic Organ Prolapse Incontinence Sexual Questionnaire is a 20 item questionnaire and is the primary measure used to assess sexual function in women with urinary incontinence and prolapse. Mean subscale scores are calculated by summing the valid responses to items in the subscale and then divided by the number of items with valid responses. The higher the subscores, the worse the outcome.

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026